Spots Global Cancer Trial Database for burkitt's lymphoma
Every month we try and update this database with for burkitt's lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Treatment for Advanced B-Cell Lymphoma | NCT01859819 | Diffuse Large C... Burkitt's Lymph... High Grade B-ce... | Rituximab IT Cytarabine | 3 Years - 31 Years | New York Medical College | |
| Treg Cells for AGVHD in Non-myeloablative UCB Transplant | NCT02118311 | Hematologic Mal... | T Regulatory ce... Fludarabine Cyclophosphamid... Total Body Irra... | 18 Years - 69 Years | Masonic Cancer Center, University of Minnesota | |
| Safety and Tolerability of HSC835 in Patients With Hematological Malignancies | NCT01474681 | Acute Myelocyti... Acute Lymphocyt... Chronic Myeloge... Myelodysplastic... Chronic Lymphoc... Marginal Zone L... Follicular Lymp... Large-cell Lymp... Lymphoblastic L... Burkitt's Lymph... High Grade Lymp... Mantle-cell Lym... Lymphoplasmacyt... | HSC835 | 10 Years - 55 Years | Novartis | |
| Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas | NCT00001237 | Burkitt Lymphom... Lymphoma, Large... Lymphoma, Small... | granulocyte-mac... | - | National Institutes of Health Clinical Center (CC) | |
| Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt's or Burkitt-like Lymphoma in Adults | NCT01809600 | Burkitt's Lymph... High-grade B-ce... | No intervention... | 20 Years - | Gachon University Gil Medical Center | |
| Autologous Transplant in HIV Patients (BMT CTN 0803) | NCT01141712 | Lymphoma HIV | Autologous tran... BCNU Etoposide Cytarabine Melphalan | 15 Years - | Medical College of Wisconsin | |
| MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine | NCT01397825 | Diffuse Large B... Transformed Fol... Mantle Cell Lym... Burkitt's Lymph... | Alisertib (MLN8... Rituximab Vincristine | 18 Years - | Takeda | |
| Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases | NCT02145039 | Acute Leukemias Burkitt's Lymph... Chronic Myeloge... | Fludarabine Cyclophosphamid... Total Body Irra... Haploidentical ... | - 74 Years | Masonic Cancer Center, University of Minnesota | |
| CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL) | NCT01134575 | Acute Lymphobla... | CMC-544 (Inotuz... Rituximab | 16 Years - | M.D. Anderson Cancer Center | |
| Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL | NCT00187161 | Non-Hodgkin Lym... Acute Lymphobla... | Prednison, Vinc... | - 18 Years | St. Jude Children's Research Hospital | |
| Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma | NCT01516593 | HIV Burkitt's Lymph... | Induction Phase Consolidation P... Intensification... BEAM conditioni... Consolidation r... | 18 Years - 60 Years | IRCCS San Raffaele | |
| Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients | NCT00949741 | Diffuse Large C... Lymphoblastic L... Burkitt's Lymph... | 18 Years - | Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie | ||
| Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL | NCT00187161 | Non-Hodgkin Lym... Acute Lymphobla... | Prednison, Vinc... | - 18 Years | St. Jude Children's Research Hospital | |
| T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies | NCT01163201 | Hematologic Mal... Acute Myeloid L... Acute Lymphocyt... Chronic Myeloge... Anemia, Refract... Chronic Myelopr... Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Large Cell Non-... Lymphoblastic L... Burkitt's Lymph... High Grade Non-... | Treg cells CD3+ Teff cells Fludarabine Cyclophosphamid... Total body irra... Umbilical cord ... | 18 Years - 55 Years | Masonic Cancer Center, University of Minnesota | |
| CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL) | NCT01134575 | Acute Lymphobla... | CMC-544 (Inotuz... Rituximab | 16 Years - | M.D. Anderson Cancer Center | |
| Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma | NCT00669877 | Burkitt's Lymph... Burkitt'S-like ... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone G-CSF Cytarabine Methotrexate | - | M.D. Anderson Cancer Center | |
| MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine | NCT01397825 | Diffuse Large B... Transformed Fol... Mantle Cell Lym... Burkitt's Lymph... | Alisertib (MLN8... Rituximab Vincristine | 18 Years - | Takeda | |
| T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies | NCT01163201 | Hematologic Mal... Acute Myeloid L... Acute Lymphocyt... Chronic Myeloge... Anemia, Refract... Chronic Myelopr... Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Large Cell Non-... Lymphoblastic L... Burkitt's Lymph... High Grade Non-... | Treg cells CD3+ Teff cells Fludarabine Cyclophosphamid... Total body irra... Umbilical cord ... | 18 Years - 55 Years | Masonic Cancer Center, University of Minnesota | |
| Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma | NCT01516593 | HIV Burkitt's Lymph... | Induction Phase Consolidation P... Intensification... BEAM conditioni... Consolidation r... | 18 Years - 60 Years | IRCCS San Raffaele | |
| Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases | NCT02145039 | Acute Leukemias Burkitt's Lymph... Chronic Myeloge... | Fludarabine Cyclophosphamid... Total Body Irra... Haploidentical ... | - 74 Years | Masonic Cancer Center, University of Minnesota | |
| Rituximab Combined With Chemotherapy in Burkitt's Lymphoma | NCT00388193 | Acute Lymphobla... Burkitt's Lymph... | RITUXIMAB | 15 Years - | PETHEMA Foundation | |
| 19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers | NCT04464200 | Diffuse Large B... Primary Mediast... Transformed Fol... Chronic Lymphoc... Indolent Non-Ho... Marginal Zone L... Waldenstrom Mac... Burkitt's Lymph... Primary CNS Lym... | 19(T2)28z1xx CA... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Treg Cells for AGVHD in Non-myeloablative UCB Transplant | NCT02118311 | Hematologic Mal... | T Regulatory ce... Fludarabine Cyclophosphamid... Total Body Irra... | 18 Years - 69 Years | Masonic Cancer Center, University of Minnesota | |
| Double Cord Versus Haploidentical (BMT CTN 1101) | NCT01597778 | Acute Lymphocyt... Acute Myelogeno... Burkitt's Lymph... Follicular Lymp... Hodgkin Lymphom... Mantle Cell Lym... Non-Hodgkin Lym... | Haploidentical ... Double Umbilica... | 18 Years - 70 Years | Medical College of Wisconsin | |
| Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors | NCT00001301 | Lymphoma, Non-H... | - | National Institutes of Health Clinical Center (CC) | ||
| Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases | NCT01962636 | Acute Myeloid L... Acute Lymphocyt... Chronic Myeloge... Plasma Cell Leu... Myelofibrosis Myelodysplasia Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Diffuse Large B... Lymphoblastic L... Burkitt's Lymph... Non-Hodgkin Lym... Multiple Myelom... | Fludarabine Cyclophosphamid... Total Body Irra... Cyclosporine A Mycophenylate m... Umbilical cord ... | - 55 Years | Masonic Cancer Center, University of Minnesota | |
| Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases | NCT01962636 | Acute Myeloid L... Acute Lymphocyt... Chronic Myeloge... Plasma Cell Leu... Myelofibrosis Myelodysplasia Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Diffuse Large B... Lymphoblastic L... Burkitt's Lymph... Non-Hodgkin Lym... Multiple Myelom... | Fludarabine Cyclophosphamid... Total Body Irra... Cyclosporine A Mycophenylate m... Umbilical cord ... | - 55 Years | Masonic Cancer Center, University of Minnesota | |
| Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases | NCT02145039 | Acute Leukemias Burkitt's Lymph... Chronic Myeloge... | Fludarabine Cyclophosphamid... Total Body Irra... Haploidentical ... | - 74 Years | Masonic Cancer Center, University of Minnesota |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
